Abstract
The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.
Full Text
What is claimed is:
The present disclosure provides prodrug compounds of MDMA, MDA, and derivatives thereof having an improved pharmacokinetic profile suitable for the treatment of various neurological diseases.
Timeline
Filed
04/10/2026Published
08/06/2026Granted
Not AvailableIPC Codes(3)
C07D 317/58:Radicals substituted by nitrogen atoms (nitro radicals C07D 317/52)
C07D 411/12:linked by a chain containing hetero atoms as chain links
C07F 9/30:Phosphinic acids [R2=P(:O)OH]; Thiophosphinic acids